CRISPR-Based Anti-Viral Therapy Could One Day Foil the Flu—and COVID-19

CRISPR-Based Anti-Viral Therapy Could One Day Foil the Flu—and COVID-19

This new anti-viral CRISPR system also relies on guide RNA. Earlier studies by other groups had shown the potential of Cas13 for degrading the RNA of influenza viruses in a lab dish [2,3]. Rather than delivering the Cas13a protein itself to the lungs, the CRISPR system works by supplying a messenger RNA (mRNA) with the instructions to make the anti-viral Cas13a protein. Directed by the guide RNA that was also delivered to the same cells, Cas13a degrades the viral RNA and stops the infection. In mice with influenza, Cas13a degraded influenza RNA in the lungs and the animals recovered without any apparent side effects.

About Us

At Wellness Axis we want to encourage habits of wellness, Increase awareness of factors and resources contributing to well-being, Inspire and empower individuals to take responsibility for their own health, and to support a sense of community. Wellness can be thought of as the quality or state of being in good health.

Subscribe to our newsletter!